Please login to the form below

Not currently logged in
Email:
Password:

Zeltiq Aesthetics

This page shows the latest Zeltiq Aesthetics news and features for those working in and with pharma, biotech and healthcare.

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal. Expands aesthetic pharma business with “ best-in-class” body contouring system. ... Botox manufacturer Allergan has bolstered its cosmetic product portfolio once again, signing a $2.48bn agreement to

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Following its spate of deals last year, Allergan is paying $2.48bn ($56.50 per share, a 14.4% premium) to acquire ZELTIQ Aesthetics to enhance its global medical aesthetics portfolio. ... Royalty monetisation. 2, 850. ZELTIQ Aesthetics/ Allergan.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Genoscience Pharma expands board of directors Genoscience Pharma expands board of directors

    He most recently served as Pharmcyclics' chief financial officer and treasurer and has also held management positions at ZELTIQ Aesthetics and PriceWaterhouseCoopers, where he worked in PwC's San Jose office

  • Versartis names chief financial officer Versartis names chief financial officer

    He already has life sciences financial experience, having previously served as chief financial officer for Zeltiq Aesthetics and director of finance at Proteolix.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics